Risk factors for increased antimicrobial resistance: a retrospective analysis of 309 acute cholangitis episodes

Jochen Schneider1, Pierre De Waha, Alexander Hapfelmeier

  • 1Institute of Medical Microbiology, Immunology and Hygiene, Technische Universität München, München, Germany.

Abstract

Insights

Stent therapy increases antimicrobial resistance in patients with acute cholangitis. Numerous prior interventional procedures further elevate this risk, impacting treatment effectiveness.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Enterobacteriaceae are common pathogens in biliary tract infections.
  • Antimicrobial resistance (AMR) poses a significant challenge in managing acute cholangitis.
  • Identifying risk factors for AMR is crucial for effective treatment strategies.

Purpose of the Study:

  • To identify risk factors associated with increased antimicrobial resistance in Enterobacteriaceae causing acute cholangitis.
  • To evaluate the impact of interventions and patient characteristics on resistance patterns.

Main Methods:

  • Retrospective analysis of 276 patients with acute cholangitis.
  • Comparison of resistance patterns in Enterobacteriaceae from blood/bile cultures.
  • Analysis of risk factors including age, sex, cholangitis genesis, and interventional procedures (percutaneous transhepatic cholangiography/endoscopic retrograde cholangiography).
  • Utilized univariate and multivariate generalized estimation equation models.

Main Results:

  • Stent therapy was associated with a lower proportion of susceptible Enterobacteriaceae to quinolones and ceftriaxone.
  • Patients undergoing stent therapy had a 4-fold higher odds of acquiring ceftriaxone-resistant Enterobacteriaceae.
  • Each additional interventional procedure (PTC/ERC) decreased susceptibility to multiple antibiotics, including quinolones and ceftriaxone.
  • Age, sex, and type of intervention were not significant risk factors for AMR.

Conclusions:

  • Stent therapy is a significant risk factor for developing antimicrobial resistance in acute cholangitis.
  • A higher number of prior interventional procedures exacerbates the risk of antimicrobial resistance.
  • These findings highlight the need for careful consideration of interventions in patients with biliary infections and emerging resistance.

Related Concept Videos

Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Acute Pancreatitis I: Introduction01:25

Acute Pancreatitis I: Introduction

Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...